News Medical's "Thought Leaders" series is a selection of articles written by national and
international experts and trusted advisers in health and medicine. All the articles are
written by experts who have been invited as recognised leaders in their fields to provide
a "state of the art" contribution.
An interview with The Drake Foundation, discussing the short and long-term effects of concussions obtained during contact sports such as football and rugby.
Mohit Nair discusses the issue of antibiotic resistance in India and the work that MSF is doing to improve awareness and reduce the misuse of antibiotics.
In this interview, Marco Versiani discusses how he uses micro-CT in dentistry for the Root Canal Anatomy Project.
We asked Dr. Lion Shahab, one of the UK's leading experts on e-cigarettes and smoking, to provide the truth about the safety of vaping and for his advice to people giving up cigarettes this World Cancer Day.
An interview with Professor Attila Lorincz, discussing the development of a new cervical cancer test that is able to predict cervical cancer and pre-cancer in 100% cases.
In this interview, Dr. Polinski and Dr. Atabakhsh discuss the importance of developing biomarkers for Parkinson’s and the partnership between MJFF and Abcam.
An interview with Professor William Newman, discussing his recent discovery in the field of breast cancer research, and the options that this will provide for women who have a family history of breast cancer but test negative for BRCA1/2 mutations.
Dr. Neil Ebenezer from the charity Fight for Sight discusses the steps you can take to protect your eyesight into old age, and why research into ophthalmic diseases is desperately needed.
An interview with Dr. Steven Simpson, MD, discussing the importance of raising awareness of the signs and symptoms of sepsis, and how Sepsis Alliance is helping to reduce the number of deaths caused by sepsis in the USA.
In this interview, Dr. Imalka Jayawardena from the University of Surrey talks about the development of a flexible X-ray detector that will help clinicians analyze X-ray images and deliver targeted doses of radiation when using X-rays as a treatment.
Dr. Barbara Jefferis from UCL discusses the importance of exercise in later life and how her research is challenging current UK physical activity guidelines for men.
At St. John's, we are building an innovation center in pharmaceutical technology. We are involved with double upping new drug delivery systems, as well as a new processing agreement. In addition, we are focussing on personalized medications.
With the advent of artificial intelligence, it is imperative that we examine the ethics of machine learning and data collection. Hugh Whittall, Director of the Nuffield Council on Bioethics, explains what AI is, how it is transforming the healthcare industry and the ethical concerns of the Council.
One year on from the WHO's Global Action Plan for Dementia, Dr. Matthew Norton from Alzheimer's Research UK discusses the steps that have been taken so far, and whether we are likely to meet the 2025 target.
Studying the effects of gravity on muscle cells can give us an insight into muscle wastage diseases, and potentially guide the development of new therapies. Professor Louis Yuge discusses his research and the cellular changes that occur in response to microgravity.
Dr. Jinghui Zhang, an esteemed computational biologist at St. Jude Children's Research Hospital discusses her latest study and how technology such as cloud computing is changing the way that scientists carry out research.
The work that we're doing in particular involves the development of better models of the human body. To do that, we need to put together cells, tissues, culture them in an artificial environment so that they feel as if they're inside the human body.
Following the Zika virus epidemic that swept across Brazil between 2015-2016, Dr. Julia Clarke and her team begun working to establish the long-term effects of Zika, and recently discovered that TNF-a inhibitors can be used to prevent microencephaly.
Dr. Cedric Garland discusses the results of a 12-year cohort study which showed that vitamin D3 can prevent type 1 diabetes in 80 percent of cases.
Chi-En Lin won Metrohm’s Young Chemist of the Year award for his research into optimal biomarker frequencies, not just the novelty of the research but how it can be applied. Determining optimal biomarker frequencies for multimarker biosensors has wide ranging uses from rapid cancer screening methodologies, dry diagnostics, providing personalized medicine and helping to detect comorbidities before they become a problem.